Regan J. Barry's most recent trade in Dexcom Inc was a trade of 1,675 Common Stock done at an average price of $121.9 . Disclosure was reported to the exchange on Dec. 18, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
DexCom | Regan J. Barry | EVP Operations | Sale or transfer of securities back to the company at price $ 121.85 per share. | 18 Dec 2023 | 1,675 | 58,469 (0%) | 0% | 121.9 | 204,099 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale of securities on an exchange or to another person at price $ 128.05 per share. | 10 Jul 2023 | 1,989 | 66,269 (0%) | 0% | 128.0 | 254,691 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale of securities on an exchange or to another person at price $ 124.50 per share. | 20 Apr 2023 | 2,214 | 68,258 (0%) | 0% | 124.5 | 275,643 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 3,274 | 72,482 (0%) | 0% | 111.4 | 364,720 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale or transfer of securities back to the company at price $ 111.40 per share. | 10 Mar 2023 | 2,406 | 75,756 (0%) | 0% | 111.4 | 268,026 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale of securities on an exchange or to another person at price $ 106.27 per share. | 10 Mar 2023 | 2,010 | 70,472 (0%) | 0% | 106.3 | 213,603 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 18,776 | 78,162 (0%) | 0% | 0.0 | 19 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale of securities on an exchange or to another person at price $ 106.12 per share. | 30 Jan 2023 | 2,213 | 59,386 (0%) | 0% | 106.1 | 234,844 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale or transfer of securities back to the company at price $ 112.62 per share. | 21 Nov 2022 | 3,781 | 61,599 (0%) | 0% | 112.6 | 425,818 | Common Stock |
DexCom | Barry J. Regan | EVP Global Operations | Sale of securities on an exchange or to another person at price $ 500.00 per share. | 29 Mar 2022 | 1,106 | 16,345 (0%) | 0% | 500 | 553,000 | Common Stock |
DexCom | Barry J. Regan | EVP Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 4,984 | 18,112 (0%) | 0% | 0.0 | 5 | Common Stock |
DexCom | Barry J. Regan | EVP Global Operations | Sale or transfer of securities back to the company at price $ 406.06 per share. | 08 Mar 2022 | 661 | 17,451 (0%) | 0% | 406.1 | 268,403 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2021 | 1,671 | 13,128 (0%) | 0% | 0.0 | 2 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale of securities on an exchange or to another person at price $ 563.93 per share. | 13 Dec 2021 | 1,214 | 11,457 (0%) | 0% | 563.9 | 684,611 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Sale of securities on an exchange or to another person at price $ 638.65 per share. | 22 Nov 2021 | 837 | 12,671 (0%) | 0% | 638.6 | 534,550 | Common Stock |
DexCom | Barry J. Regan | EVP Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 5,301 | 13,508 (0%) | 0% | 0.0 | 5 | Common Stock |